Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...
Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th.
Investors with a lot of money to spend have taken a bearish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the trades showed up on publicly ...
Abbott (ABT) ended the recent trading session at $134.92, demonstrating a +1.31% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of ...
Abbott Laboratories closed 10.57% short of its 52-week high of $141.23, which the company reached on March 4th.
Among the largest underlying components of XLV, in trading today Abbott Laboratories (Symbol: ABT) is up about 1.1%, Thermo Fisher Scientific Inc (Symbol: TMO) is off about 0.8%, and Pfizer Inc ...